Registry name: German Clinical Trials Register (DRKS)
Year established: 2008
Points of interest:
- The DRKS was funded by the Federal Ministry of Education and Research (BMBF) and implemented at the Center for Medical Biometry and Medical Informatics at the University Medical Center Freiburg.
- Since 2017, the DRKS was maintained by the German Institute of Medical Documentation and Information (DIMDI)
- Since October 2008, the DRKS has been approved as a WHO Primary Register and complies with the International Committee of Medical Journal Editors (ICMJE) requirements
- The goal of the DRKS, as stated on their website, is to provide a central portal for information on clinical research in Germany
- The DRKS cooperates with the German Society of Urology and the German Cancer Society
- Information on the register is available in both German and English
- The DRKS is the only study registry in Germany recognized by the WHO
- While Germany does not legally require clinical trials to be registered, all trials that include patients in Germany should be registered in DRKS
Related transparency research/articles:
- The German Clinical Trials Register – an additional source for drug information
- WHO: German Clinical Trials Register
- The German Clinical Trials Register: challenges and chances of implementing a bilingual registry
TrialAssure® Registry can automate the disclosure of clinical trial results for DRKS. For questions or a free demo, fill out this form.